Special Issue "The Cytopathology of Metastatic Breast Cancer"
A special issue of Journal of Molecular Pathology (ISSN 2673-5261).
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 10783
Interests: molecular pathology; cytopathology; breast cancer
Cytology has long been an integral part of the management of primary and metastatic cancers. Aspiration cytology is particularly favored for the assessment of breast cancers, as the breast and axillary lymph nodes are both superficial and cosmetically sensitive. In addition to cytomorphologic diagnoses, cytological material can be processed for ancillary testing. The demand and application of cytology on metastatic breast cancer is consistently expanding with the advancement in radiological and endoscopic techniques for obtaining cytological samples, evolution in histological and cytological classification of breast cancers, and in the increase in biomarkers and molecular tests available for advanced breast cancers. This Special Issue aims to address the recent developments in the cytopathology of metastatic breast cancers, including the diagnostic approach to identify a metastatic lesion originated from breast, histological correlation in the identification of subtypes, assessment of nodal diseases and the application of immunohistochemical and molecular tests in cytological materials.
Prof. Dr. Fernando Schmitt
Prof. Dr. Gary M. K. Tse
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Molecular Pathology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- fine needle aspiration cytology